<p>Basilea Pharmaceutica AG (OTCMKTS:BPMUF - 獲取免費報告) 的股價在週一的盤中交易中創下了新的 52 周高點。該公司股價最高達到 72.66 美元，最後交易價格為 72.66 美元，成交量為 11 股。該股票此前收盤價為 72.14 美元。</p>
<p>獲取 <strong>Basilea Pharmaceutica</strong> 的提醒：</p>
<h2>Basilea Pharmaceutica 價格表現</h2>
<p>該股票的 50 日移動平均線為 63.99 美元，200 日移動平均線為 64.79 美元。公司的債務與股本比率為 0.79，流動比率為 6.32，速動比率為 5.67。</p>
<h2>關於 Basilea Pharmaceutica</h2>
<p>(獲取免費報告)</p>
<p>Basilea Pharmaceutica AG 是一家總部位於瑞士巴塞爾的生物製藥公司，專注於醫院治療疾病的創新療法的開發和商業化。公司的研究主要集中在抗感染和腫瘤學領域，擁有涵蓋已上市產品和早期至晚期管道候選藥物的產品組合。Basilea 利用藥物化學專業知識來解決真菌感染、細菌感染和癌症等關鍵醫療需求。</p>
<p>其主要產品之一是伊沙伏康唑，這是一種廣譜抗真菌藥物，商品名為 Cresemba。</p>
<h2>相關文章</h2>
<ul>
<li>五隻我們更看好的股票，勝過 Basilea Pharmaceutica</li>
<li>您的簽名缺失 - 在為時已晚之前採取行動</li>
<li>什麼費用可以從資本利得税中扣除？</li>
<li>用這四個簡單步驟讓您的銀行賬户 “防聯儲”</li>
<li>埃隆是否在為銀價震盪做準備？</li>
<li>在週一上午 9:30 購買這隻股票！</li>
</ul>
<p><em>此即時新聞提醒由敍事科學技術和來自 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>您現在應該投資 1,000 美元於 Basilea Pharmaceutica 嗎？</h2>
<p>在您考慮 Basilea Pharmaceutica 之前，您需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前... 而 Basilea Pharmaceutica 並不在名單上。</p>
<p>雖然 Basilea Pharmaceutica 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

<p>Basilea Pharmaceutica (OTCMKTS:BPMUF) 在交易中達到了新的 52 周高點 72.66 美元，成交量為 11 股。該股票的前一交易日收盤價為 72.14 美元，50 日移動平均線為 63.99 美元。該公司專注於生物製藥，主要研究抗感染藥物和腫瘤學。儘管股票表現良好，分析師目前將其評級為持有，暗示可能存在更好的投資機會</p>

<p>Basilea Pharmaceutica AG (OTCMKTS:BPMUF - Get Free Report)'s share price hit a new 52-week high during mid-day trading on Monday . The company traded as high as $72.66 and last traded at $72.66, with a volume of 11 shares traded. The stock had previously closed at $72.14.</p>
<div class="lb-trans"><p>Basilea Pharmaceutica AG (OTCMKTS:BPMUF - 獲取免費報告) 的股價在週一的盤中交易中創下了新的 52 周高點。該公司股價最高達到 72.66 美元，最後交易價格為 72.66 美元，成交量為 11 股。該股票此前收盤價為 72.14 美元。</p>
</div><p>Get <strong>Basilea Pharmaceutica</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Basilea Pharmaceutica</strong> 的提醒：</p>
</div><h2>Basilea Pharmaceutica Price Performance</h2>
<div class="lb-trans"><h2>Basilea Pharmaceutica 價格表現</h2>
</div><p>The stock has a 50-day moving average of $63.99 and a two-hundred day moving average of $64.79. The company has a debt-to-equity ratio of 0.79, a current ratio of 6.32 and a quick ratio of 5.67.</p>
<div class="lb-trans"><p>該股票的 50 日移動平均線為 63.99 美元，200 日移動平均線為 64.79 美元。公司的債務與股本比率為 0.79，流動比率為 6.32，速動比率為 5.67。</p>
</div><h2>About Basilea Pharmaceutica</h2>
<div class="lb-trans"><h2>關於 Basilea Pharmaceutica</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(獲取免費報告)</p>
</div><p>Basilea Pharmaceutica AG is a Swiss biopharmaceutical company headquartered in Basel, specializing in the development and commercialization of innovative treatments for hospital‐treated diseases. The company's research is focused primarily on anti‐infectives and oncology, with a portfolio that spans both marketed products and early‐ to late‐stage pipeline candidates. Basilea leverages medicinal chemistry expertise to address critical medical needs in fungal infections, bacterial infections and cancer.</p>
<div class="lb-trans"><p>Basilea Pharmaceutica AG 是一家總部位於瑞士巴塞爾的生物製藥公司，專注於醫院治療疾病的創新療法的開發和商業化。公司的研究主要集中在抗感染和腫瘤學領域，擁有涵蓋已上市產品和早期至晚期管道候選藥物的產品組合。Basilea 利用藥物化學專業知識來解決真菌感染、細菌感染和癌症等關鍵醫療需求。</p>
</div><p>Among its lead products is isavuconazole, a broad‐spectrum antifungal agent marketed under the trade name Cresemba.</p>
<div class="lb-trans"><p>其主要產品之一是伊沙伏康唑，這是一種廣譜抗真菌藥物，商品名為 Cresemba。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>相關文章</h2>
</div><ul>
<li>Five stocks we like better than Basilea Pharmaceutica</li>
<li>Your Signature Is Missing – Act Before It’s Too Late</li>
<li>What Expenses Can Be Deducted From Capital Gains Tax?</li>
<li>“Fed Proof” Your Bank Account with THESE 4 Simple Steps</li>
<li>Is Elon Preparing for a Silver Shock?</li>
<li>Buy This Stock at 9:30 AM on MONDAY!</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過 Basilea Pharmaceutica</li>
<li>您的簽名缺失 - 在為時已晚之前採取行動</li>
<li>什麼費用可以從資本利得税中扣除？</li>
<li>用這四個簡單步驟讓您的銀行賬户 “防聯儲”</li>
<li>埃隆是否在為銀價震盪做準備？</li>
<li>在週一上午 9:30 購買這隻股票！</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和來自 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Basilea Pharmaceutica Right Now?</h2>
<div class="lb-trans"><h2>您現在應該投資 1,000 美元於 Basilea Pharmaceutica 嗎？</h2>
</div><p>Before you consider Basilea Pharmaceutica, you'll want to hear this.</p>
<div class="lb-trans"><p>在您考慮 Basilea Pharmaceutica 之前，您需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Basilea Pharmaceutica wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前... 而 Basilea Pharmaceutica 並不在名單上。</p>
</div><p>While Basilea Pharmaceutica currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Basilea Pharmaceutica 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Basilea Pharmaceutica (OTCMKTS:BPMUF) 創下 52 周新高 - 你是否應該購買？